Sponsored
Video
Nimesh Desai, MD, Shares His Perspective on Recently Published 5-Year Outcomes in Acute Complicated Type B Aortic Dissection
11/01/2025
The US IDE Clinical Trial, Type B Dissection, initiated in 2010 with 50 patients across 26 U.S. sites, is the first study to look at TEVAR for acute, complicated type B aortic dissections. Listen in as National Principal Investigator, Nimesh Desai, MD, shares his perspective on the key long-term outcomes of this study.
Click the photo below to watch the video!
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:
Subscribe Now!
Vascular Disease Management Newsletter
